Table 1: Belimumab levels and CD19+ B-cells values measured in a mother-child pair at delivery, at 4 and 7 months postpartum.
Table 1: Belimumab levels and CD19+ B-cells values measured in a mother-child pair at delivery, at 4 and 7 months postpartum.